To compare the effect of Vamana, Virechana, and Basti on serum adiponectin levels in patients of T2DM with obesity (sthula pramehi)

A COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFECT OF VAMANA, VIRECHANA AND BASTI ON SERUM ADIPONECTIN LEVEL IN THE MANAGEMENT OF T2DM WITH OBESITY (STHULA PRAMEHI) AN EXPLORATORY STUDY - nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/10/096255

Enrollment

Registered

2025-10-21

Start date

Unknown

Completion date

Unknown

Last updated

2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient having classical signs and symptoms of Diabesity or Sthula Pramehi according to Ayurveda as well as modern science. Patients diagnosed with Diabetes or Pre-Diabetes. Body Mass Index more than twenty-three and less than forty kilograms per meter square. Fasting Blood Sugar more than one hundred ten milligrams per decilitre and up to two hundred milligrams per decilitre. Postprandial Blood Sugar more than one hundred forty milligrams per decilitre and up to three hundred milligrams per decilitre. HbA1c between five point seven and seven point zero percent. Age between thirty to sixty years. Any gender. All socio-economic statuses included. Patient must be fit for Ayurvedic procedures including Vamana Virechana and Basti.

Exclusion criteria

Exclusion criteria: Age less than 30 years and more than 60 years. Patients of Prameha having Body Mass Index less than 23 kg per square meter and more than 40 kg per square meter. Patients with chronicity of disease more than five years. Patients diagnosed with Type 1 Diabetes Mellitus. Patients having complications of diabetes such as nephropathy diabetic ulcer etc. Pregnant and lactating women. Patients having high blood pressure more than 160 by 100 millimeters of mercury.

Design outcomes

Primary

Measure	Time frame
an improvement in serum adiponectin levels following intervention with vamana, virechana and basti.Timepoint: 0th day,50th day	—

Secondary

Measure	Time frame
objective parameter- An improvement in BMI, waist circumference, hip-waist ratio, FBS, PPBS, HbA1c, lipid profile subjective parameter-An improvement in signs & symptoms based on ayurvedic & modern parameters . Improvement in quality of life Results will guide future controlled trials & integrative management strategies. Timepoint: 0th day,20th day,50th day,100th day	—

Countries

India

Contacts

Public ContactDr Nicky Yadav

All India Institute of Ayurveda

santoshbhatted@rediffmail.com9414048459

Outcome results